ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures

Millions of people undergo either diagnostic or therapeutic coronary procedures that require sedation. The aim of this study was to assess whether food restriction is necessary before sedation in these procedures. 

This was a randomized study in centers of Australia. Patients were randomly assigned 1:1 to two groups: the fasting group (6 hours with no solid food and 2 without any liquids) and the no restriction group (habitual diet).

The primary outcome was a composite of events including aspiration pneumonia, hypotension, hyper and hypo glycaemia. 

716 patients were included, mean age 69, 35% women. Primary end point occurred in 19.1% of the fasting group and 12% of the regular diet group. Upon intention to treat analysis, the net difference was -5.2% in favor of the no fast group, confirming non inferiority for this strategy.

Read also: ESC 2024 | SENIOR RITA: Invasive Strategy for Elderly Patients with ACS.

As regards patient satisfaction, it was significantly higher in the no fast group (15±4.3 vs. 11±4.0 satisfaction).

This study, together with the CHOW-NOW, TONIC and Fast-CIED studies, shows there is solid evidence in favor of the lack of benefit of fasting prior these kind of procedures. 

Presented by David Ferreia at Hot-Line Sessions, ESC Congress 2024, August 30 thru September 2, London, England  


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...